The post-pandemic environment — and the continuing digital health revolution — offers a range of risks and opportunities for dealmakers.
Health care transactions are driven by regulations. Buyers, sellers, and investors may face significant risk if their deals are not properly structured, so they often engage separate special regulatory and transactional counsel to handle their transactions. We offer comprehensive, end-to-end service to handle all aspects of our clients' transactions, from fraud and abuse, Stark, licensing, and reimbursement; to due diligence, corporate issues and M&A. Working with us provides key advantages, such as our collective knowledge of, and experience in, the health care markets; seamless service, and the efficiencies developed from years of working as a team.
Sponsored Events
06.26.24
2024 ACG New York 16th Annual Healthcare Conference
Sponsored Events
05.21.24
2024 Philadelphia Alliance for Capital and Technologies (PACT) Enterprise Awards
Sponsored Events
04.16.24
2024 Bloom Burton & Co. Healthcare Investor Conference
Articles + Publications
04.16.24
California's AB 3129: Implications for Private Equity Investments in Physician Practices
Firm News
04.10.24
Troutman Pepper Advises Leading Global Clinical Trial Supply Company Myonex in Back-to-Back Acquisitions
Articles + Publications
03.15.24
"Market Practice Needs to Check Itself" – A Reminder from the Court of Chancery that M&A Practitioners Must Strictly Abide by Statutory Requirements When Approving Mergers